2012
Behavioural and neurochemical changes induced by stress-related conditions are counteracted by the neurokinin-2 receptor antagonist saredutant
TAMBURELLA, Alessandra; Gian Marco LEGGIO; Vincenzo MICALE; Andrea NAVARRIA; Claudio BUCOLO et al.Základní údaje
Originální název
Behavioural and neurochemical changes induced by stress-related conditions are counteracted by the neurokinin-2 receptor antagonist saredutant
Autoři
TAMBURELLA, Alessandra; Gian Marco LEGGIO; Vincenzo MICALE; Andrea NAVARRIA; Claudio BUCOLO; Valentina CICIRATA; Filippo DRAGO a Salvatore SALOMONE
Vydání
International Journal of Neuropsychopharmacology, 2012
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30000 3. Medical and Health Sciences
Stát vydavatele
Švédsko
Utajení
není předmětem státního či obchodního tajemství
Označené pro přenos do RIV
Ne
Klíčová slova anglicky
Brain-derived neurotrophic factor, corticosterone, forced swim test, NK2 receptor antagonist, restraint stress
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 18. 10. 2012 13:04, Olga Křížová
Anotace
V originále
These experiments were undertaken to assess the mechanisms underlying the antidepressant-like effects of the neurokinin-2 (NK2) receptor antagonist saredutant (SR48968) in rats tested in the forced swim test (FST), by analysing hippocampal brain-derived neurotrophic factor (BDNF) and plasma corticosterone [as index of hypothalamic-pituitary-adrenal (HPA) axis activity]. Male Wistar rats received three intraperitoneal injections over 24 h of vehicle, saredutant (5 mg/kg), citalopram (15 mg/kg), clomipramine (50 mg/kg). Rats were subjected to restraint stress (4 h) 24 h prior to the FST procedure. This stress procedure increased immobility and decreased swimming behaviour in the FST; furthermore, it lowered hippocampal BDNF protein expression and increased plasma corticosterone levels. Saredutant and clomipramine or citalopram, used here as positive controls, reduced the immobility time in the FST both under basal conditions and after stress exposure. This effect was not attributable to changes in locomotion, because locomotor activity was unchanged when assessed in the open field test. Pretreatment with paracholorophenylalanine (150 mg/kg, 72 h and 48 h prior to FST) abolished the effect of citalopram and saredutant on immobility time. At neurochemical level, saredutant attenuated activation of HPA axis in stressed animals more than clomipramine or citalopram. The behavioural effects of saredutant support the hypothesis that NK2 receptor activity is involved in stress-related disorders. These effects of saredutant may be related to normalization of the HPA axis. Moreover, saredutant increases BDNF expression in the hippocampus, confirming the role of NK2 receptor blockade in BDNF activation following stressor application.